| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |